Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): first real-life data from the cohort temporary authorization for use (cATU) program in France
Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): first real-life data from the cohort temporary authorization for use (cATU) program in France ### Output: Trastuzumab Deruxtecan